Proteomic analysis of human omental adipose tissue in the polycystic ovary syndrome using two-dimensional difference gel electrophoresis and mass spectrometry.
about
Genetic, hormonal and metabolic aspects of PCOS: an updatePoly Cystic Ovarian Syndrome: An Updated OverviewThe striking similarities in the metabolic associations of female androgen excess and male androgen deficiencyRecent advances in proteomic studies of adipose tissues and adipocytesProteomic analysis of endometrium from fertile and infertile patients suggests a role for apolipoprotein A-I in embryo implantation failure and endometriosisProteomic analysis of epicardial and subcutaneous adipose tissue reveals differences in proteins involved in oxidative stress.Power of proteomics in linking oxidative stress and female infertility.MECHANISMS IN ENDOCRINOLOGY: The sexually dimorphic role of androgens in human metabolic disease.Gene expression in subcutaneous adipose tissue differs in women with polycystic ovary syndrome and controls matched pair-wise for age, body weight, and body mass index.Characterization of the Human Adipocyte Proteome and Reproducibility of Protein Abundance by One-Dimensional Gel Electrophoresis and HPLC-ESI-MS/MS.No difference in markers of adipose tissue inflammation between overweight women with polycystic ovary syndrome and weight-matched controls.Lipidomic analysis of plasma samples from women with polycystic ovary syndrome.Cyclostreptin derivatives specifically target cellular tubulin and further map the paclitaxel site.Proteomic analysis of gastric cancer and immunoblot validation of potential biomarkers.Defining the role of bariatric surgery in polycystic ovarian syndrome patients.Apolipoprotein A1 as a novel anti-implantation biomarker in polycystic ovary syndrome: A case-control studyOvarian and adipose tissue dysfunction in polycystic ovary syndrome: report of the 4th special scientific meeting of the Androgen Excess and PCOS Society.Tackling the human adipose tissue proteome to gain insight into obesity and related pathologies.Framework for a systems approach to proteomic biomarker profiling in polycystic ovary syndrome.Proteomic characterization of adipose tissue constituents, a necessary step for understanding adipose tissue complexity.Application of proteomics technology in adipocyte biology.Proteomics and polycystic ovary syndrome.A mass spectrometric insight into the origins of benign gynecological disorders.Combining a nontargeted and targeted metabolomics approach to identify metabolic pathways significantly altered in polycystic ovary syndrome.Effect of dietary monosodium glutamate on HFCS-induced hepatic steatosis: expression profiles in the liver and visceral fat.The Role of Androgen Excess in Metabolic Dysfunction in Women : Androgen Excess and Female Metabolic Dysfunction.Transcriptome profiles in peripheral white blood cells at the time of artificial insemination discriminate beef heifers with different fertility potential.Validation of proteomic biomarkers previously found to be differentially expressed in women with polycystic ovary syndrome: a cross-sectional study.Comparative Proteomic Analysis of Two Differently Extracted Coptis chinensis in the Treatment of Type 2 Diabetic RatsObesity Proteomics: An Update on the Strategies and Tools Employed in the Study of Human Obesity
P2860
Q26740034-66BB66BC-779B-4972-B905-EE36450AA1BAQ26752564-A08B596E-3354-4117-9531-6C686EE32D86Q26828981-5D0487FB-6040-4270-8B80-E0A92B76146DQ27026109-0CB28211-0CCB-41D7-A248-9960D635AE29Q33518313-37455ECA-CC6C-4239-B88C-5E123C1E9A23Q33570051-C062ED5D-37E7-43E2-B42D-3C1850A749F7Q33677951-BBBFEE27-3A8B-4331-B472-14D420EE92D6Q33904576-AD43F479-1FC3-48C2-AF2E-3866CDA395C8Q33946386-94C24D69-DDF1-4D45-A48F-327881017790Q34109923-3C82C431-51BE-42FA-87E0-07553724A8B9Q34987386-2FAE0DF2-C4D7-4AC4-930F-A26CE6C341F7Q35567919-8AA00DFD-4B49-43DB-8C13-C646C6D14DDFQ35664859-79371951-8A38-441C-873D-144C12FF1C7DQ35845396-6925DFB8-BF63-4302-839D-C753B4F8BAC9Q35906974-A19CC238-8BEA-4146-BC83-CDAC7DBB985EQ36584287-068A1F7A-D914-4EC1-8542-5FC34F3AE201Q37055049-017E2F6F-C662-4D87-9714-37FDC90ECED1Q37579894-6C8AF231-7BCF-4185-A19F-4DF6A8B4A1BBQ37610304-FFAF8B04-DAC9-4634-807C-652560BB4D76Q37975960-C20E7329-CC42-4C6A-ABA6-AEA05E6B5E5EQ38102925-393F2A17-8510-4965-AE79-155878D599DAQ38148579-E6BA0125-E06E-42A5-8D7E-E20C2525BE16Q38657980-134FB246-FE4C-4D57-85CE-E6B7D3D2198EQ38776405-8F0D6AF2-B136-4B00-9DFD-5709CFBE969AQ43181274-5EA3E69C-A431-4721-95F9-8B41A0279FA3Q47567144-D312C68C-5CDA-43D5-9E4F-CF991209E5D4Q49800535-4EF0B6CC-46C7-4402-B467-3A95A42A5526Q50736240-59746F0C-5B22-4F79-B0A6-82C32EE0FB1CQ57300387-FF4E0644-652C-4767-A091-866AF2DFC606Q58745201-EF822BAC-3108-4D33-B13F-2B042958A1EF
P2860
Proteomic analysis of human omental adipose tissue in the polycystic ovary syndrome using two-dimensional difference gel electrophoresis and mass spectrometry.
description
2007 nî lūn-bûn
@nan
2007 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2007 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
name
Proteomic analysis of human om ...... horesis and mass spectrometry.
@ast
Proteomic analysis of human om ...... horesis and mass spectrometry.
@en
Proteomic analysis of human om ...... horesis and mass spectrometry.
@nl
type
label
Proteomic analysis of human om ...... horesis and mass spectrometry.
@ast
Proteomic analysis of human om ...... horesis and mass spectrometry.
@en
Proteomic analysis of human om ...... horesis and mass spectrometry.
@nl
prefLabel
Proteomic analysis of human om ...... horesis and mass spectrometry.
@ast
Proteomic analysis of human om ...... horesis and mass spectrometry.
@en
Proteomic analysis of human om ...... horesis and mass spectrometry.
@nl
P2093
P50
P356
P1433
P1476
Proteomic analysis of human om ...... horesis and mass spectrometry.
@en
P2093
Belén Peral
Emilio Camafeita
Héctor F Escobar-Morreale
José I Botella-Carretero
José L San Millán
Juan A López
Marta Cortón
P304
P356
10.1093/HUMREP/DEM380
P407
P577
2007-12-22T00:00:00Z